Reported earnings, while also down, did not concern Wall Street’s analyst corps who liked what they saw. Saying “backlog is as high as it has ever been,” Stryker Corporation reported $5.8 billion in ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...

SYK risks include potential volatility in hospital CAPEX spending, which could impact Stryker’s capital equipment business growth. Stryker posted its Q1 FY 2025 result on May 1, posting 10.1% ...

Terry Smith has a long track record of outperforming the market with a strategy heavily influenced by Warren Buffett. Smith is much more heavily invested in technology stocks than Buffett, and ...

Ronda E Stryker, Director at Stryker SYK, executed a substantial insider sell on May 8, according to an SEC filing. Stryker designs, manufactures, and markets an array of medical equipment ...

In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other best medical device stocks to buy now. On April 16, CNBC reported that Trump’s tariffs ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...

Stryker SYK has outperformed the market over the past 10 years by 4.9% on an annualized basis producing an average annual return of 15.23%. Currently, Stryker has a market capitalization of $146. ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers. The medical devices industry ...

First, the authors investigated the ligands for CLEC9A by establishing a reporter system composed of the extracellular domains of CLEC9A fused to CD3ζ and expressed by T cells; in this system ...